With Europe’s population living longer, the quest for new Alzheimer’s disease (AD) therapies has never been more urgent. Researchers hope that figuring out which genes and environmental factors trigger the illness will deliver drugs that prevent serious memory loss.
Africans and Asians who migrate to Europe have a higher risk of diabetes than indigenous people as they adjust to a different diet and lifestyle. By looking at the development of diabetes in these groups, researchers hope to find out more about the disease and how to combat it both in Europe and worldwide.
‘You will never become a scientist!’ For his teachers, a science career for John Gurdon, was no more than hypothetical. But the British professor who won the 2012 Nobel Prize for Medicine has only one piece of advice for aspiring researchers: ‘Don’t give up!’
Diabetes is on the rise all around the world. In the EU alone, there are 33 million people diagnosed with diabetes. They include people of all ages and from all walks of life. The two main forms are insulin-dependent Type-1 diabetes and non-insulin-dependent Type-2 diabetes. Type-1 diabetes, which develops mainly in children and adolescents, is more aggressive. However the disease is not a tragedy, as three ‘Type-1’ patients explain.
An experimental tablet treatment for child diabetes, where youngsters have traditionally had to inject themselves with sugar controlling insulin, could end up eradicating the disease altogether, according to the scientist leading the European NAIMIT project.
It all started with the chance discovery of a country lane full of wild orchids by an inquisitive young girl in rural England. That young girl, Frances Ashcroft, would go on to become one of Europe’s leading diabetes researchers.
Complex and painful disease has been historically overlooked, researchers say.
Robin Garrity says that registration, identification and geofencing will increase security.
Chemical switches on DNA could explain how the environment may influence the traits we pass on, according to Prof. Thomas Carell.